Diversified Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,381
| Closed | -$314K | – | 903 |
|
|
2023
Q4 | $314K | Buy |
2,381
+267
| +13% | +$35.2K | 0.01% | 646 |
|
|
2023
Q3 | $238K | Buy |
+2,114
| New | +$238K | 0.01% | 699 |
|
|
2023
Q2 | – | Sell |
-2,316
| Closed | -$234K | – | 883 |
|
|
2023
Q1 | $234K | Buy |
2,316
+143
| +7% | +$14.5K | 0.01% | 715 |
|
|
2022
Q4 | $260K | Sell |
2,173
-64
| -3% | -$7.66K | 0.01% | 635 |
|
|
2022
Q3 | $238K | Buy |
+2,237
| New | +$238K | 0.01% | 629 |
|
|
2013
Q3 | – | Sell |
-21,960
| Closed | -$294K | – | 475 |
|
|
2013
Q2 | $294K | Buy |
+21,960
| New | +$294K | 0.04% | 398 |
|